Helios Optics is driven to make the world's eye care better by delivering advanced diagnostics that harness the power of information technology to provide the most accurate patient results. Helios flagship device, SunCrown, diagnoses dry eye syndrome using a method that significantly out-performs other methods on both a per-test cost and performance basis.
SunCrown's patent pending technology provides efficient, quantitative, reliable, trackable, and a non-invasive approach, making this new diagnostic the preferred method by eye care professionals and patients alike. Dry eye syndrome affects nearly 40 million people in the US and 100 million people worldwide and rising with aging population and lifestyle environmental shifts. DES can impact a person's daily activities, however in more severe cases, DES can lead to permanent loss of vision if not handled appropriately. SunCrown has successfully met animal and initial human testing milestones, and will reach prototyping development soon.